Author Interviews, Depression, JAMA, LSD-Psychodelics / 19.05.2026
Karolinska Institutet Evaluates Single Dose of Psilocybin for Depression
Editor's note: This piece discusses mental health issues. If you have experienced suicidal thoughts or have lost someone to suicide and want to seek help, you can contact the Crisis Text Line by texting "START" to 741-741 or call the Suicide Prevention Lifeline at 800-273-8255.
[caption id="attachment_73822" align="alignleft" width="200"]
Dr. Hampus Yngwe[/caption]
MedicalResearch.com Interview with:
Hampus Yngwe, MD, MSc
Centre for Psychiatry Research,
Department of Clinical Neuroscience,
Karolinska Institutet, and
Stockholm Health Care Services
Stockholm, Sweden
MedicalResearch.com: What is the background for this study?
Response: Depression is a common and disabling condition and current treatments do not work for all patients. Psilocybin has shown promise as a rapid-acting treatment, but more controlled studies are needed to clarify its effects, durability and safety.
Dr. Hampus Yngwe[/caption]
MedicalResearch.com Interview with:
Hampus Yngwe, MD, MSc
Centre for Psychiatry Research,
Department of Clinical Neuroscience,
Karolinska Institutet, and
Stockholm Health Care Services
Stockholm, Sweden
MedicalResearch.com: What is the background for this study?
Response: Depression is a common and disabling condition and current treatments do not work for all patients. Psilocybin has shown promise as a rapid-acting treatment, but more controlled studies are needed to clarify its effects, durability and safety.